BIBR 1532 (5 mg) Telomerase Inhibitor X; 2-[[(2E)-3-(2-naphthalenyl)-1-oxo-2-buten-1-yl]amino]-benzoic acid Cayman 16608-5 970.2/5 mg 详情
BIBR 1532 (50 mg) Telomerase Inhibitor X; 2-[[(2E)-3-(2-naphthalenyl)-1-oxo-2-buten-1-yl]amino]-benzoic acid Cayman 16608-50 6545/50 mg 详情
BVT 948 (1 mg) 4-hydroxy-3,3-dimethyl-2H-benz[g]indole-2,5(3H)-dione Cayman 16615-1 385/1 mg 详情
BVT 948 (10 mg) 4-hydroxy-3,3-dimethyl-2H-benz[g]indole-2,5(3H)-dione Cayman 16615-10 1355.2/10 mg 详情
BVT 948 (5 mg) 4-hydroxy-3,3-dimethyl-2H-benz[g]indole-2,5(3H)-dione Cayman 16615-5 862.4/5 mg 详情
MAB-CHMINACA (1 mg) ADB-CHMINACA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide Cayman 16616-1 规格或产品已更新 详情
MAB-CHMINACA (10 mg) ADB-CHMINACA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide Cayman 16616-10 规格或产品已更新 详情
MAB-CHMINACA (5 mg) ADB-CHMINACA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide Cayman 16616-5 规格或产品已更新 详情
Bupivacaine (1 g) 1-butyl- N-(2, 6- dimethylphenyl)-2- piperidinecarboxamid e Cayman 16618-1 616/1 g 详情
Bupivacaine (25 g) 1-butyl- N-(2, 6- dimethylphenyl)-2- piperidinecarboxamid e Cayman 16618-25 2695/25 g 详情
Bupivacaine (5 g) 1-butyl- N-(2, 6- dimethylphenyl)-2- piperidinecarboxamid e Cayman 16618-5 847/5 g 详情
Bupivacaine (500 mg) 1-butyl- N-(2, 6- dimethylphenyl)-2- piperidinecarboxamid e Cayman 16618-500 385/500 mg 详情
SD 208 (1 mg) TGF-β RI Kinase Inhibitor V; 2-(5-chloro-2-fluorophenyl)-N-4-pyridinyl-4-pteridinamine Cayman 16619-1 446.6/1 mg 详情
SD 208 (10 mg) TGF-β RI Kinase Inhibitor V; 2-(5-chloro-2-fluorophenyl)-N-4-pyridinyl-4-pteridinamine Cayman 16619-10 2233/10 mg 详情
SD 208 (25 mg) TGF-β RI Kinase Inhibitor V; 2-(5-chloro-2-fluorophenyl)-N-4-pyridinyl-4-pteridinamine Cayman 16619-25 5020.4/25 mg 详情
SD 208 (5 mg) TGF-β RI Kinase Inhibitor V; 2-(5-chloro-2-fluorophenyl)-N-4-pyridinyl-4-pteridinamine Cayman 16619-5 1339.8/5 mg 详情
Mito-TEMPO (hydrate) (1 mg) 2,2,6,6-tetramethyl-4-[[2-(triphenylphosphonio)acetyl]amino]-1-piperidinyloxy, monochloride, monohydrate Cayman 16621-1 385/1 mg 详情
Mito-TEMPO (hydrate) (10 mg) 2,2,6,6-tetramethyl-4-[[2-(triphenylphosphonio)acetyl]amino]-1-piperidinyloxy, monochloride, monohydrate Cayman 16621-10 1509.2/10 mg 详情
Mito-TEMPO (hydrate) (25 mg) 2,2,6,6-tetramethyl-4-[[2-(triphenylphosphonio)acetyl]amino]-1-piperidinyloxy, monochloride, monohydrate Cayman 16621-25 3372.6/25 mg 详情
Mito-TEMPO (hydrate) (5 mg) 2,2,6,6-tetramethyl-4-[[2-(triphenylphosphonio)acetyl]amino]-1-piperidinyloxy, monochloride, monohydrate Cayman 16621-5 862.4/5 mg 详情
Cyproterone Acetate (1 g) Androcur|CPA|Cyprostat|NSC 81430|SH 714; (1β,2β)-17-acetyloxy-6-chloro-1,2-dihydro-3'H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione Cayman 16622-1 4312/1 g 详情
Cyproterone Acetate (100 mg) Androcur|CPA|Cyprostat|NSC 81430|SH 714; (1β,2β)-17-acetyloxy-6-chloro-1,2-dihydro-3'H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione Cayman 16622-100 539/100 mg 详情
Cyproterone Acetate (250 mg) Androcur|CPA|Cyprostat|NSC 81430|SH 714; (1β,2β)-17-acetyloxy-6-chloro-1,2-dihydro-3'H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione Cayman 16622-250 1278.2/250 mg 详情
Kanosamine (hydrochloride) (1 mg) 3-amino-3-deoxy-D-glucose, monohydrochloride Cayman 16623-1 539/1 mg 详情
Kanosamine (hydrochloride) (10 mg) 3-amino-3-deoxy-D-glucose, monohydrochloride Cayman 16623-10 4312/10 mg 详情
Kanosamine (hydrochloride) (25 mg) 3-amino-3-deoxy-D-glucose, monohydrochloride Cayman 16623-25 9501.8/25 mg 详情
Kanosamine (hydrochloride) (5 mg) 3-amino-3-deoxy-D-glucose, monohydrochloride Cayman 16623-5 2433.2/5 mg 详情
SB 590885 (1 mg) 5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-(4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro-1H-inden-1-one oxime Cayman 16643-1 600.6/1 mg 详情
SB 590885 (10 mg) 5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-(4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro-1H-inden-1-one oxime Cayman 16643-10 2402.4/10 mg 详情
SB 590885 (25 mg) 5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-(4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro-1H-inden-1-one oxime Cayman 16643-25 5251.4/25 mg 详情
SB 590885 (5 mg) 5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-(4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro-1H-inden-1-one oxime Cayman 16643-5 1509.2/5 mg 详情
Wnt-C59 (1 mg) PORCN Inhibitor II; 4 - (2 -methyl -4 - pyridinyl) - N - [4 - (3 - pyridinyl) phenyl] -benzeneacetamide Cayman 16644-1 539/1 mg 详情
Wnt-C59 (10 mg) PORCN Inhibitor II; 4 - (2 -methyl -4 - pyridinyl) - N - [4 - (3 - pyridinyl) phenyl] -benzeneacetamide Cayman 16644-10 2156/10 mg 详情
Wnt-C59 (5 mg) PORCN Inhibitor II; 4 - (2 -methyl -4 - pyridinyl) - N - [4 - (3 - pyridinyl) phenyl] -benzeneacetamide Cayman 16644-5 1355.2/5 mg 详情
Wnt-C59 (50 mg) PORCN Inhibitor II; 4 - (2 -methyl -4 - pyridinyl) - N - [4 - (3 - pyridinyl) phenyl] -benzeneacetamide Cayman 16644-50 9163/50 mg 详情
Mozavaptan (hydrochloride) (10 mg) OPC 31260; N-[4-[[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]phenyl]-2-methyl-benzamide, monohydrochloride Cayman 16664-10 862.4/10 mg 详情
Mozavaptan (hydrochloride) (100 mg) OPC 31260; N-[4-[[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]phenyl]-2-methyl-benzamide, monohydrochloride Cayman 16664-100 7007/100 mg 详情
Mozavaptan (hydrochloride) (5 mg) OPC 31260; N-[4-[[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]phenyl]-2-methyl-benzamide, monohydrochloride Cayman 16664-5 539/5 mg 详情
Mozavaptan (hydrochloride) (50 mg) OPC 31260; N-[4-[[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]phenyl]-2-methyl-benzamide, monohydrochloride Cayman 16664-50 3773/50 mg 详情
Melphalan (100 mg) Alanine Nitrogen Mustard|Alkeran|L-Phenylalanine Mustard|NSC 241286|NSC 8806; 4- [bis(2- chloroethyl) amino] -L- phenylalanine Cayman 16665-100 1801.8/100 mg 详情
Melphalan (250 mg) Alanine Nitrogen Mustard|Alkeran|L-Phenylalanine Mustard|NSC 241286|NSC 8806; 4- [bis(2- chloroethyl) amino] -L- phenylalanine Cayman 16665-250 3249.4/250 mg 详情
Melphalan (50 mg) Alanine Nitrogen Mustard|Alkeran|L-Phenylalanine Mustard|NSC 241286|NSC 8806; 4- [bis(2- chloroethyl) amino] -L- phenylalanine Cayman 16665-50 1001/50 mg 详情
Melphalan (500 mg) Alanine Nitrogen Mustard|Alkeran|L-Phenylalanine Mustard|NSC 241286|NSC 8806; 4- [bis(2- chloroethyl) amino] -L- phenylalanine Cayman 16665-500 5005/500 mg 详情
Monocrotaline (10 mg) Crotaline|MCT|NSC 28693; (3R,4R,5R)-4,5,8,10,12,13,13aR,13bR-octahydro-4,5-dihydroxy-3,4,5-trimethyl-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione Cayman 16666-10 规格或产品已更新 详情
Monocrotaline (100 mg) Crotaline|MCT|NSC 28693; (3R,4R,5R)-4,5,8,10,12,13,13aR,13bR-octahydro-4,5-dihydroxy-3,4,5-trimethyl-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione Cayman 16666-100 1432.2/100 mg 详情
Monocrotaline (5 mg) Crotaline|MCT|NSC 28693; (3R,4R,5R)-4,5,8,10,12,13,13aR,13bR-octahydro-4,5-dihydroxy-3,4,5-trimethyl-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione Cayman 16666-5 规格或产品已更新 详情
Monocrotaline (50 mg) Crotaline|MCT|NSC 28693; (3R,4R,5R)-4,5,8,10,12,13,13aR,13bR-octahydro-4,5-dihydroxy-3,4,5-trimethyl-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione Cayman 16666-50 754.6/50 mg 详情
BMS 345541 (trifluoroacetate salt) (1 mg) IKK Inhibitor III; N1- (1, 8- dimethylimidazo[1, 2- a] quinoxalin- 4- yl) -1, 2- ethanediamine, trifluoroacetate salt Cayman 16667-1 523.6/1 mg 详情
BMS 345541 (trifluoroacetate salt) (10 mg) IKK Inhibitor III; N1- (1, 8- dimethylimidazo[1, 2- a] quinoxalin- 4- yl) -1, 2- ethanediamine, trifluoroacetate salt Cayman 16667-10 3927/10 mg 详情
BMS 345541 (trifluoroacetate salt) (25 mg) IKK Inhibitor III; N1- (1, 8- dimethylimidazo[1, 2- a] quinoxalin- 4- yl) -1, 2- ethanediamine, trifluoroacetate salt Cayman 16667-25 7207.2/25 mg 详情
首页 公司简介 新闻中心 产品中心 特色产品 技术专栏 在线订购 联系我们

版权所有 艾美捷科技有限公司

地址:武汉市洪山区光谷大道35号光谷总部国际二期时代1栋13楼 邮政编码:430074

电话:+86-027-59626688 全国免费技术支持: 400-6800-868 传真:+86-027-59716800

鄂ICP备10204150号

Abbkine Scientific   亚科因科技